169 related articles for article (PubMed ID: 22542283)
1. Lipophilic amines as potent inhibitors of N-acylethanolamine-hydrolyzing acid amidase.
Yamano Y; Tsuboi K; Hozaki Y; Takahashi K; Jin XH; Ueda N; Wada A
Bioorg Med Chem; 2012 Jun; 20(11):3658-65. PubMed ID: 22542283
[TBL] [Abstract][Full Text] [Related]
2. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.
Sun YX; Tsuboi K; Zhao LY; Okamoto Y; Lambert DM; Ueda N
Biochim Biophys Acta; 2005 Oct; 1736(3):211-20. PubMed ID: 16154384
[TBL] [Abstract][Full Text] [Related]
3. N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA).
Ueda N; Tsuboi K; Uyama T
Prog Lipid Res; 2010 Oct; 49(4):299-315. PubMed ID: 20152858
[TBL] [Abstract][Full Text] [Related]
4. N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation.
Alhouayek M; Bottemanne P; Makriyannis A; Muccioli GG
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 May; 1862(5):474-484. PubMed ID: 28065729
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase.
Saturnino C; Petrosino S; Ligresti A; Palladino C; De Martino G; Bisogno T; Di Marzo V
Bioorg Med Chem Lett; 2010 Feb; 20(3):1210-3. PubMed ID: 20022504
[TBL] [Abstract][Full Text] [Related]
6. N-acylethanolamine hydrolyzing acid amidase inhibition: tools and potential therapeutic opportunities.
Bottemanne P; Muccioli GG; Alhouayek M
Drug Discov Today; 2018 Aug; 23(8):1520-1529. PubMed ID: 29567427
[TBL] [Abstract][Full Text] [Related]
7. N-cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase.
Tsuboi K; Hilligsmann C; Vandevoorde S; Lambert DM; Ueda N
Biochem J; 2004 Apr; 379(Pt 1):99-106. PubMed ID: 14686878
[TBL] [Abstract][Full Text] [Related]
8. N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice.
Bottemanne P; Guillemot-Legris O; Paquot A; Masquelier J; Malamas M; Makriyannis A; Alhouayek M; Muccioli GG
Neurotherapeutics; 2021 Jul; 18(3):1815-1833. PubMed ID: 34235639
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors.
Malamas MS; Farah SI; Lamani M; Pelekoudas DN; Perry NT; Rajarshi G; Miyabe CY; Chandrashekhar H; West J; Pavlopoulos S; Makriyannis A
Bioorg Med Chem; 2020 Jan; 28(1):115195. PubMed ID: 31761726
[TBL] [Abstract][Full Text] [Related]
10. The N-acylethanolamine-hydrolyzing acid amidase (NAAA).
Tsuboi K; Takezaki N; Ueda N
Chem Biodivers; 2007 Aug; 4(8):1914-25. PubMed ID: 17712833
[TBL] [Abstract][Full Text] [Related]
11. Different roles for the acyl chain and the amine leaving group in the substrate selectivity of
Ghidini A; Scalvini L; Palese F; Lodola A; Mor M; Piomelli D
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1411-1423. PubMed ID: 34256657
[No Abstract] [Full Text] [Related]
12. Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives.
Li Y; Chen Q; Yang L; Li Y; Zhang Y; Qiu Y; Ren J; Lu C
Eur J Med Chem; 2017 Oct; 139():214-221. PubMed ID: 28802121
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase.
Tsuboi K; Sun YX; Okamoto Y; Araki N; Tonai T; Ueda N
J Biol Chem; 2005 Mar; 280(12):11082-92. PubMed ID: 15655246
[TBL] [Abstract][Full Text] [Related]
14. Endogenous molecules stimulating N-acylethanolamine-hydrolyzing acid amidase (NAAA).
Tai T; Tsuboi K; Uyama T; Masuda K; Cravatt BF; Houchi H; Ueda N
ACS Chem Neurosci; 2012 May; 3(5):379-85. PubMed ID: 22860206
[TBL] [Abstract][Full Text] [Related]
15. Advances in the discovery of N-acylethanolamine acid amidase inhibitors.
Bandiera T; Ponzano S; Piomelli D
Pharmacol Res; 2014 Aug; 86():11-7. PubMed ID: 24798679
[TBL] [Abstract][Full Text] [Related]
16. Progress in the development of β-lactams as N-Acylethanolamine Acid Amidase (NAAA) inhibitors: Synthesis and SAR study of new, potent N-O-substituted derivatives.
Petracca R; Ponzano S; Bertozzi SM; Sasso O; Piomelli D; Bandiera T; Bertozzi F
Eur J Med Chem; 2017 Jan; 126():561-575. PubMed ID: 27915171
[TBL] [Abstract][Full Text] [Related]
17. Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies.
Tsuboi K; Zhao LY; Okamoto Y; Araki N; Ueno M; Sakamoto H; Ueda N
Biochim Biophys Acta; 2007 May; 1771(5):623-32. PubMed ID: 17462942
[TBL] [Abstract][Full Text] [Related]
18. Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis.
Migliore M; Pontis S; Fuentes de Arriba AL; Realini N; Torrente E; Armirotti A; Romeo E; Di Martino S; Russo D; Pizzirani D; Summa M; Lanfranco M; Ottonello G; Busquet P; Jung KM; Garcia-Guzman M; Heim R; Scarpelli R; Piomelli D
Angew Chem Int Ed Engl; 2016 Sep; 55(37):11193-11197. PubMed ID: 27404798
[TBL] [Abstract][Full Text] [Related]
19. Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells.
Wang J; Zhao LY; Uyama T; Tsuboi K; Wu XX; Kakehi Y; Ueda N
J Biochem; 2008 Nov; 144(5):685-90. PubMed ID: 18806270
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors.
Ponzano S; Bertozzi F; Mengatto L; Dionisi M; Armirotti A; Romeo E; Berteotti A; Fiorelli C; Tarozzo G; Reggiani A; Duranti A; Tarzia G; Mor M; Cavalli A; Piomelli D; Bandiera T
J Med Chem; 2013 Sep; 56(17):6917-34. PubMed ID: 23991897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
